[{"id":"78ef7659-8d3d-4df9-b4a9-a9556d985a98","acronym":"","url":"https://clinicaltrials.gov/study/NCT05159518","created_at":"2021-12-16T14:54:02.338Z","updated_at":"2024-07-02T16:35:26.597Z","phase":"Phase 1","brief_title":"A Study of PRT2527 in Participants With Advanced Solid Tumors","source_id_and_acronym":"NCT05159518","lead_sponsor":"Prelude Therapeutics","biomarkers":" HER-2 • MYC","pipe":" | ","alterations":" HR positive • HER-2 negative • MYC amplification","tags":["HER-2 • MYC"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HR positive • HER-2 negative • MYC amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PRT2527"],"overall_status":"Completed","enrollment":" Enrollment 30","initiation":"Initiation: 02/14/2022","start_date":" 02/14/2022","primary_txt":" Primary completion: 12/06/2023","primary_completion_date":" 12/06/2023","study_txt":" Completion: 12/06/2023","study_completion_date":" 12/06/2023","last_update_posted":"2023-12-11"}]